Some other food for thought,
Company was floated at $20M with 101M shares issued at 0.20c 15months ago.
Has since achieved TGA approval, setup distribution in ANZ, US and parts of EU, and have been expanding the product portfolio.
Latest quarterly receipts grew 77%, cash outflow ~$400k per quarter with $9M+ in the bank.
Current Enterprise value sits at ~$30M.
Given the strong interest this stock has had in its early days, I think it could run again on some solid announcements.
CY Q4 results will be very interesting, if growth is sustained (as they stated) then CY21 could return CF+ quite easily.
Add to My Watchlist
What is My Watchlist?
